An Observational Study of Survival in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After 1, 3, and 5 Years of Tyrosine Kinase Inhibitor (TKI) Therapy (SIMPLICITY)

Autor: Michallet, Mauricette, Cortes, Jorge, Gambacorti-Passerini, Carlo, Hehlmann, Rüdiger, Williams, Loretta A., Goldberg, Stuart L., Davis, Catherine, De Solda, Francesco, Sen, Ginny P., Gajavelli, Srikanth, Mauro, Michael J.
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2018 18 Supplement 1:S229-S229
Databáze: ScienceDirect
Externí odkaz: